Industry: Healthcare | Publish Date: 04-Aug-2025 | No of Pages: 206 | No. of Tables: 107 | No. of Figures: 52 | Format: PDF | Report Code : HC1262
The UK Dialysis Market size was valued at USD 4.07 billion in 2023, and is expected to reach USD 5.31 billion by 2030, with a CAGR of 3.9% from 2024 to 2030.
The dialysis market is a segment of the healthcare sector focused on providing artificial kidney functions to individuals with impaired renal function. Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.
This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.
The escalating prevalence of diabetes in the UK is a major contributor to the rising incidence of chronic kidney disease (CKD), pushing more patients into end-stage renal disease (ESRD). As diabetes remains a leading underlying cause of kidney failure, the healthcare system is witnessing a heightened need for long-term dialysis therapies. This has triggered an expansion of both hemodialysis and peritoneal dialysis services nationwide, encouraging providers to invest in modern renal care infrastructure and adopt innovative treatment protocols to meet the growing patient demand.
The UK’s aging population is creating sustained pressure on the dialysis market. Older adults are more prone to conditions such as hypertension and diabetes, both of which significantly increase the risk of kidney failure. This demographic shift is intensifying the demand for consistent and accessible dialysis care tailored to the complex needs of geriatric patients. In response, healthcare providers are broadening service offerings and enhancing clinical capacity to cater to this expanding patient segment.
A critical barrier to market growth is the ongoing shortage of specialized healthcare professionals, including nephrologists, renal technicians, and dialysis-trained nurses. This gap is straining existing dialysis facilities, especially in rural and under-resourced regions, where service delivery is already limited. The resulting challenges—longer patient wait times, higher workload burdens, and reduced treatment frequency—compromise the quality and consistency of care, restricting the scalability of dialysis services across the UK.
The UK dialysis market is experiencing a transformative shift with the emergence of advanced dialysis technologies, particularly in home-based and portable systems. These innovations are revolutionizing renal care delivery by offering patients greater autonomy, reduced dependence on in-clinic sessions, and the ability to manage treatments in familiar environments. Enhanced with digital connectivity and real-time monitoring tools, these systems support more proactive and personalized care models. As the NHS and private sector alike explore decentralized treatment strategies, the expansion of tech-enabled, patient-centric dialysis options presents a compelling growth pathway for both service providers and medical device manufacturers.
Several market players operating in the UK dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company (BD), NiprCorporation TerumEurope NV, NikkisCo., Ltd., Quanta Dialysis Technologies Ltd., Outset Medical, Inc., Toray Medical Co., Ltd., W. L. Gore & Associates, Inc.,, Teleflex Incorporated, Vantive Health LLC, Asahi Kasei Corporation, Pennine Healthcare Ltd and others.
Hemodialysis (HD)
Hemodialysis Machines
In-center HD
Home HD
Water Treatment Systems
Central water-disinfection units
Point-of-use/portable systems
Ancillary/Other HD Equipment
UF/ultrafiltration pumps
Dialysis chairs/beds
Disinfection/sterilization units
Monitoring & data-capture hardware
HD Consumables & Supplies
Dialyzers
Bloodlines & Tubing Sets
Dialysis Fluids / Concentrates
Vascular Access Products
Other HD Consumables & Accessories
HD Aftermarket Services
Repair & Maintenance
Installation & Commissioning
Training & Technical Support
Peritoneal Dialysis (PD)
PD Cyclers / Automated PD Machines
Ancillary PD Equipment
PD Consumables & Supplies
PD Dialysis Solutions
PD Catheters & Access Systems
Transfer Sets & Tubing
Other PD Supplies / Accessories
PD Aftermarket Services
Repair & Maintenance (Cyclers & Heaters)
Installation & Commissioning
Training & Technical Support
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
Fresenius Medical Care AG & Co. KGaA
Baxter International Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company (BD)
NiprCorporation
TerumEurope NV
NikkisCo., Ltd.
Quanta Dialysis Technologies Ltd.
Outset Medical, Inc.
Toray Medical Co., Ltd.
W. L. Gore & Associates, Inc.
Teleflex Incorporated
Vantive Health LLC
Asahi Kasei Corporation
Pennine Healthcare Ltd
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Market Size in 2023 |
USD 4.07 Billion |
Revenue Forecast in 2030 |
USD 5.31 Billion |
Growth Rate |
CAGR of 3.9% from 2024 to 2030 |
Analysis Period |
2023–2030 |
Base Year Considered |
2023 |
Forecast Period |
2024–2030 |
Market Size Estimation |
Billion (USD) |
Growth Factors |
|
Companies Profiled |
10 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |